David A. Hokey
Aeras(US)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Immunodeficiency and Autoimmune Disorders, Immunotherapy and Immune Responses, Immune responses and vaccinations, Mycobacterium research and diagnosis
Most-Cited Works
- → Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination(2018)656 cited
- → A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human(2014)239 cited
- → Immunostimulation of dendritic cells by cationic liposomes(2006)182 cited
- → The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial(2018)159 cited
- → Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques(2008)145 cited
- → Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review(2020)129 cited
- → Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial(2018)112 cited
- → Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen(2008)93 cited
- → Aerosol Vaccination with AERAS-402 Elicits Robust Cellular Immune Responses in the Lungs of Rhesus Macaques but Fails To Protect against High-Dose Mycobacterium tuberculosis Challenge(2014)92 cited
- → Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid(2007)87 cited